1,696
Views
74
CrossRef citations to date
0
Altmetric
Review Article

Paracetamol: overdose-induced oxidative stress toxicity, metabolism, and protective effects of various compounds in vivo and in vitro

, , , , , , & show all
Pages 395-437 | Received 24 Mar 2017, Accepted 05 Jul 2017, Published online: 16 Aug 2017

References

  • Abdul Hamid Z, Budin SB, Wen Jie N, Hamid A, Husain K, Mohamed J. 2012. Nephroprotective effects of Zingiber zerumbet Smith ethyl acetate extract against paracetamol-induced nephrotoxicity and oxidative stress in rats. J Zhejiang Univ Sci B. 13:176–185.
  • Abraham P. 2005. Oxidative stress in paracetamol-induced pathogenesis: (I). Renal damage. Indian J Biochem Biophys. 42:59–62.
  • Adams L, Franco MC, Estevez AG. 2015. Reactive nitrogen species in cellular signaling. Exp Biol Med (Maywood, NJ). 240:711–717.
  • Alderman CJ, Shah S, Foreman JC, Chain BM, Katz DR. 2002. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Biol Med. 32:377–385.
  • Ali BH, Bashir AK, Rasheed RA. 2001. Effect of the traditional medicinal plants Rhazya stricta, Balanitis aegyptiaca and Haplophylum tuberculatum on paracetamol-induced hepatotoxicity in mice. Phytother Res. 15:598–603.
  • Ali M, Chang PS, Haque R, Bhatia K, Ahmad S. 2014. Habb-e-Asgand, polyherbal Unani formulation, protects liver and antioxidative enzymes against paracetamol induced hepatotoxicity. Pharm Biol. 52:506–515.
  • Amar PJ, Schiff ER. 2007. Acetaminophen safety and hepatotoxicity—where do we go from here? Expert Opin Drug Saf. 6:341–355.
  • Aouacheri W, Saka S, Djafer R, Lefranc G. 2009. Protective effect of diclofenac towards the oxidative stress induced by paracetamol toxicity in rats. Ann Biol Clin. 67:619–627.
  • Arafa HM. 2009. Carnitine deficiency: a possible risk factor in paracetamol hepatotoxicity. Arch Toxicol. 83:139–150.
  • Ashok Kumar BS, Lakshman K, Arun Kumar PA, Viswantha GLS, Veerapur VP, Thippeswamy BS, Manoj B. 2011. Hepatoprotective activity of methanol extract of Amaranthus caudatus Linn. against paracetamol-induced hepatic injury in rats. Zhong Xi Yi Jie He Xue Bao. 9:194–200.
  • Athira S, Mann B, Sharma R, Kumar R. 2013. Ameliorative potential of whey protein hydrolysate against paracetamol-induced oxidative stress. J Dairy Sci. 96:1431–1437.
  • Aydin B. 2011. Effects of thiacloprid, deltamethrin and their combination on oxidative stress in lymphoid organs, polymorphonuclear leukocytes and plasma of rat. Pestic Biochem Physiol. 100:165–171.
  • Bader A, Petters O, Keller M, Pavlica S. 2011. Paracetamol treatment increases telomerase activity in rat embryonic liver cells. Pharmacol Rep. 63:1435–1441.
  • Balamurugan M. 2007. Restoration of histoarchitecture in the paracetamol-induced liver damaged rat by earthworm extract, Lampito mauritii (Kinberg). Eur Rev Med Pharmacol Sci. 11:407–411.
  • Banerjee S, Melnyk SB, Krager KJ, Aykin-Burns N, McCullough SS, James LP, Hinson JA. 2017. Trifluoperazine inhibits acetaminophen-induced hepatotoxicity and hepatic reactive nitrogen formation in mice and in freshly isolated hepatocytes. Toxicol Rep. 4:134–142.
  • Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. 2006. Paracetamol: new vistas of an old drug. CNS Drug Rev. 12:250–275.
  • Bhaskar VH, Balakrishnan N. 2010. Protective effects of Pergularia daemia roots against paracetamol and carbon tetrachloride-induced hepatotoxicity in rats. Pharm Biol. 48:1265–1272.
  • Bhattacharyya S, Pence L, Beger R, Chaudhuri S, McCullough S, Yan K, Simpson P, Hennings L, Hinson J, James L. 2013. Acylcarnitine profiles in acetaminophen toxicity in the mouse: comparison to toxicity, metabolism and hepatocyte regeneration. Metabolites. 3:606–622.
  • Bi H, Li F, Krausz KW, Qu A, Johnson CH, Gonzalez FJ. 2013. Targeted metabolomics of serum acylcarnitines evaluates hepatoprotective effect of Wuzhi tablet (Schisandra sphenanthera Extract) against acute acetaminophen toxicity. Evid-Based Complement Altern Med. 2013:985257.
  • Biswas K, Kumar A, Babaria BA, Prabhu K, Setty RS. 2009. Hepatoprotective effect of leaves of Peltophorum pterocarpum against paracetamol Induced acute liver damage in rats. J Basic Clin Pharm. 1:10–15.
  • Blieden M, Paramore LC, Shah D, Ben-Joseph R. 2014. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol. 7:341–348.
  • Block TM, Mehta AS, Fimmel CJ, Jordan R. 2003. Molecular viral oncology of hepatocellular carcinoma. Oncogene. 22:5093–5107.
  • Bock KW, Forster A, Gschaidmeier H, Brück M, Münzel P, Schareck W, Fournel-Gigleux S, Burchell B. 1993. Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases. Biochem Pharmacol. 45:1809–1814.
  • Brown JM, Kuhlman C, Terneus MV, Labenski MT, Lamyaithong AB, Ball JG, Lau SS, Valentovic MA. 2014. S-adenosyl-l-methionine protection of acetaminophen mediated oxidative stress and identification of hepatic 4-hydroxynonenal protein adducts by mass spectrometry. Toxicol Appl Pharmacol. 281:174–184.
  • Bruderer R, Bernhardt OM, Gandhi T, Miladinović SM, Cheng L-Y, Messner S, Ehrenberger T, Zanotelli V, Butscheid Y, Escher C, et al. 2015. Extending the limits of quantitative proteome profiling with data-independent acquisition and application to acetaminophen-treated three-dimensional liver microtissues. Mol Cell Proteomics. 14:1400–1410.
  • Bucaretchi F, Fernandes CB, Branco MM. 2014. Acute liver failure in a term neonate after repeated paracetamol administration. Rev Paulista Pediatr. 32:144–148.
  • Budnitz DS, Lovegrove MC, Crosby AE. 2011. Emergency department visits for overdoses of acetaminophen-containing products. Am J Prev Med. 40:585–592.
  • Cao L, Li R, Chen X, Xue Y, Liu D. 2016. Neougonin A inhibits lipopolysaccharide-induced inflammatory responses via downregulation of the NF-kB signaling pathway in RAW 264.7 macrophages. Inflammation. 39:1939–1948.
  • Chaturvedi P, Machacha CN. 2007. Efficacy of Raphanus sativus in the treatment of paracetamol-induced hepatotoxicity in albino rats. Br J Biomed Sci. 64:105–108.
  • Chellappan DK, Ganasen S, Batumalai S, Candasamy M, Krishnappa P, Dua K, Chellian J, Gupta G. 2016. The protective action of the aqueous extract of Auricularia polytricha in paracetamol induced hepatotoxicity in rats. Recent Pat Drug Deliv Formulat. 10:72–76.
  • Chen C, Hennig GE, Manautou JE. 2003. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metabol Dispos. 31:798–804.
  • Dahlin DC, Miwa GT, Lu AY, Nelson SD. 1984. N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA. 81:1327–1331.
  • Dai Y, Cederbaum AI. 1995. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther. 273:1497–1505.
  • Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA, Caravati EM, Wax PM, Keyes DC, Woolf AD, et al. 2006. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Philadelphia, PA). 44:1–18.
  • Das J, Ghosh J, Manna P, Sil PC. 2010. Taurine protects acetaminophen-induced oxidative damage in mice kidney through APAP urinary excretion and CYP2E1 inactivation. Toxicology. 269:24–34.
  • Das S, Roy P, Auddy RG, Mukherjee A. 2011. Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomed. 6:1291–1301.
  • Dasuri K, Zhang L, Keller JN. 2013. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med. 62:170–185.
  • David Josephy P. 2005. The molecular toxicology of acetaminophen. Drug Metabol Rev. 37:581–594.
  • Du K, McGill MR, Xie Y, Jaeschke H. 2015. Benzyl alcohol protects against acetaminophen hepatotoxicity by inhibiting cytochrome P450 enzymes but causes mitochondrial dysfunction and cell death at higher doses. Food Chem Toxicol. 86:253–261.
  • Du K, Ramachandran A, Jaeschke H. 2016. Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential. Redox Biol. 10:148–156.
  • Ekor M, Odewabi AO, Kale OE, Bamidele TO, Adesanoye OA, Farombi EO. 2013. Modulation of paracetamol-induced hepatotoxicity by phosphodiesterase isozyme inhibition in rats: a preliminary study. J Basic Clin Physiol Pharmacol. 24:73–79.
  • El Morsy EM, Kamel R. 2015. Protective effect of artichoke leaf extract against paracetamol-induced hepatotoxicity in rats. Pharm Biol. 53:167–173.
  • Eugenio-Perez D, Montes de Oca-Solano HA, Pedraza-Chaverri J. 2016. Role of food-derived antioxidant agents against acetaminophen-induced hepatotoxicity. Pharm Biol. 54:2340–2352.
  • Fan X, Jiang Y, Wang Y, Tan H, Zeng H, Wang Y, Chen P, Qu A, Gonzalez FJ, Huang M, et al. 2014. Wuzhi tablet (Schisandra sphenanthera extract) protects against acetaminophen-induced hepatotoxicity by inhibition of CYP-mediated bioactivation and regulation of NRF2-ARE and p53/p21 pathways. Drug Metabol Dispos. 42:1982–1990.
  • Farquhar H, Stewart A, Mitchell E, Crane J, Eyers S, Weatherall M, Beasley R. 2010. The role of paracetamol in the pathogenesis of asthma. Clin Exp Allergy. 40:32–41.
  • Ferah I, Halici Z, Bayir Y, Demirci E, Unal B, Cadirci E. 2013. The role of infliximab on paracetamol-induced hepatotoxicity in rats. Immunopharmacol Immunotoxicol. 35:373–381.
  • Ferreira DW, Goedken MJ, Rommelaere S, Chasson L, Galland F, Naquet P, Manautou JE. 2016. Enhanced hepatotoxicity by acetaminophen in Vanin-1 knockout mice is associated with deficient proliferative and immune responses. Biochim Biophys Acta. 1862:662–669.
  • Firdous AP, Sindhu ER, Kuttan R. 2011. Hepato-protective potential of carotenoid meso-zeaxanthin against paracetamol, CCl4 and ethanol induced toxicity. Indian J Exp Biol. 49:44–49.
  • Galal RM, Zaki HF, Seif El-Nasr MM, Agha AM. 2012. Potential protective effect of honey against paracetamol-induced hepatotoxicity. Arch Iran Med. 15:674–680.
  • Ganetsky M, Böhlke M, Pereira L, Williams D, LeDuc B, Guatam S, Salhanick SD. 2013. Effect of excipients on acetaminophen metabolism and its implications for prevention of liver injury. J Clin Pharmacol. 53:413–420.
  • Gessi S, Borea PA, Bencivenni S, Fazzi D, Varani K, Merighi S. 2016. The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia. FEBS Lett. 590:2813–2826.
  • Gicquel T, Aubert J, Lepage S, Fromenty B, Morel I. 2013. Quantitative analysis of acetaminophen and its primary metabolites in small plasma volumes by liquid chromatography–tandem mass spectrometry. J Anal Toxicol. 37:110–116.
  • Girish C, Koner BC, Jayanthi S, Ramachandra Rao K, Rajesh B, Pradhan SC. 2009. Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharmacol. 23:735–745.
  • Gomez-Moreno G, Guardia J, Cutando A. 2008. Interaction of paracetamol in chronic alcoholic patients. Importance for odontologists. Med Oral Patol Oral Cirugia Bucal. 13:E235–E238.
  • Gow PJ, Smallwood RA, Angus PW. 1999. Paracetamol overdose in a liver transplantation centre: an 8-year experience. J Gastroenterol Hepatol. 14:817–821.
  • Graham GG, Davies MJ, Day RO, Mohamudally A, Scott KF. 2013. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 21:201–232.
  • Grypioti AD, Mykoniatis M, Demopoulos CA, Kostopanagiotou G. 2007a. Recombinant platelet-activating factor-acetylhydrolase attenuates paracetamol-induced liver oxidative stress, injury, and regeneration. Dig Dis Sci. 52:192–199.
  • Grypioti AD, Kostopanagiotou G, Mykoniatis M. 2007b. Platelet-activating factor inactivator (rPAF-AH) enhances liver's recovery after paracetamol intoxication. Dig Dis Sci. 52:2580–2590.
  • Gumbrevicius G, Sveikata A, Sveikatienė R, Stankevičius E. 2012. Paracetamol and simvastatin: a potential interaction resulting in hepatotoxicity. Medicina. 48:379–381.
  • Gündüz E, Dursun R, Zengin Y, İçer M, Durgun HM, Kanıcı A, Kaplan İ, Alabalık U, Gürbüz H, Güloğlu C. 2015. Lycium barbarum extract provides effective protection against paracetamol-induced acute hepatotoxicity in rats. Int J Clin Exp Med. 8:7898–7905.
  • Gunnell D, Murray V, Hawton K. 2000. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse. Suicide Life-Threaten Behav. 30:313–326.
  • Haldar PK, Bera S, Panda SP. 2011. Hepatoprotective activity of Cyperus tegetum rhizome against paracetamol-induced liver damage in rats. J Complement Integr Med. 8:1–10.
  • Hawton K, Ware C, Mistry H, Hewitt J, Kingsbury S, Roberts D, Weitzel H. 1996. Paracetamol self-poisoning. Characteristics, prevention and harm reduction. Br J Psychiatry. 168:43–48.
  • Hawton K, Fagg J. 1992. Trends in deliberate self poisoning and self injury in Oxford, 1976–90. BMJ (Clinical Research Ed.). 304:1409–1411.
  • Heard KJ, Green JL, James LP, Judge BS, Zolot L, Rhyee S, Dart RC. 2011. Acetaminophen-cysteine adducts during therapeutic dosing and following overdose. BMC Gastroenterol. 11:20.
  • Hegde K, Joshi AB. 2009. Hepatoprotective effect of Carissa carandas Linn root extract against CCl4 and paracetamol induced hepatic oxidative stress. Indian J Exp Biol. 47:660–667.
  • Hewawasam RP, Jayatilaka KA, Pathirana C, Mudduwa LK. 2003. Protective effect of Asteracantha longifolia extract in mouse liver injury induced by carbon tetrachloride and paracetamol. J Pharm Pharmacol. 55:1413–1418.
  • Hohmann MS, Cardoso RDR, Fattori V, Arakawa NS, Tomaz JC, Lopes NP, Casagrande R, Verri WA. 2015. Hypericum perforatum reduces paracetamol-induced hepatotoxicity and lethality in mice by modulating inflammation and oxidative stress. Phytother Res. 29:1097–1101.
  • Hu J, Ramshesh VK, McGill MR, Jaeschke H, Lemasters JJ. 2016. Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-Jun N-terminal kinase activation in mouse liver. Toxicol Sci. 150:204–215.
  • Hwang JH, Kim Y-H, Noh J-R, Gang G-T, Kim K-S, Chung HK, Tadi S, Yim Y-H, Shong M, Lee C-H, et al. 2015. The protective role of NAD(P)H:quinone oxidoreductase 1 on acetaminophen-induced liver injury is associated with prevention of adenosine triphosphate depletion and improvement of mitochondrial dysfunction. Arch Toxicol. 89:2159–2166.
  • Igami K, Shimojo Y, Ito H, Miyazaki T, Kashiwada Y. 2015. Hepatoprotective effect of fermented ginseng and its major constituent compound K in a rat model of paracetamol (acetaminophen)-induced liver injury. J Pharm Pharmacol. 67:565–572.
  • Ihsan A, Wang X, Liu Z, Wang Y, Huang X, Liu Y, Yu H, Zhang H, Li T, Yang C, et al. 2011. Long-term mequindox treatment induced endocrine and reproductive toxicity via oxidative stress in male Wistar rats. Toxicol Appl Pharmacol. 252:281–288.
  • Jaeschke H, Knight TR, Bajt ML. 2011. Current issues with acetaminophen hepatotoxicity—a clinically relevant model to test the efficacy of natural products. Life Sci. 88:737–745.
  • Jaeschke H, Knight TR, Bajt ML. 2003. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett. 144:279–288.
  • Jaeschke H, McGill MR, Ramachandran A. 2012. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metabol Rev. 44:88–106.
  • Jaeschke H, Xie Y, McGill MR. 2014. Acetaminophen-induced liver injury: from animal models to humans. J Clin Transl Hepatol. 2:153–161.
  • James L, Yan K, Pence L, Simpson P, Bhattacharyya S, Gill P, Letzig L, Kearns G, Beger R. 2015. Comparison of bile acids and acetaminophen protein adducts in children and adolescents with acetaminophen toxicity. PLoS One. 10:e0131010.
  • James LP, Chiew A, Abdel-Rahman SM, Letzig L, Graudins A, Day P, Roberts D. 2013. Acetaminophen protein adduct formation following low-dose acetaminophen exposure: comparison of immediate-release vs extended-release formulations. Eur J Clin Pharmacol. 69:851–857.
  • James LP, Mayeux PR, Hinson JA. 2003. Acetaminophen-induced hepatotoxicity. Drug Metabol Dispos: Biol Fate Chem. 31:1499–1506.
  • Jamil I, Symonds A, Lynch S, Alalami O, Smyth M, Martin J. 1999. Divergent effects of paracetamol on reactive oxygen intermediate and reactive nitrogen intermediate production by U937 cells. Int J Mol Med. 4:309–321.
  • Jetten MJ, Ruiz-Aracama A, Coonen MLJ, Claessen SM, van Herwijnen MHM, Lommen A, van Delft JHM, Peijnenburg AACM, Kleinjans JCS. 2016. Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes. Arch Toxicol. 90:1103–1115.
  • Jiang Y, Fan X, Wang Y, Tan H, Chen P, Zeng H, Huang M, Bi H. 2015. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation. Chem-Biol Interact. 231:83–89.
  • Johnson BP, Walisser JA, Liu Y, Shen AL, McDearmon EL, Moran SM, McIntosh BE, Vollrath AL, Schook AC, Takahashi JS, 2014. Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase. Proc Natl Acad Sci USA. 111:18757–18762.
  • Jones AF, Vale JA. 1993. Paracetamol poisoning and the kidney. J Clin Pharm Ther. 18:5–8.
  • Jothy SL, Aziz A, Chen Y, Sasidharan S. 2012. Antioxidant activity and hepatoprotective potential of Polyalthia longifolia and Cassia spectabilis leaves against paracetamol-induced liver injury. Evid-Based Complement Altern Med. 2012:561284.
  • Kanbur M, Eraslan G, Beyaz L, Silici S, Liman BC, Altinordulu S, Atasever A. 2009. The effects of royal jelly on liver damage induced by paracetamol in mice. Exp Toxicol Pathol. 61:123–132.
  • Karakus E, Halici Z, Albayrak A, Polat B, Bayir Y, Kiki I, Cadirci E, Topcu A, Aksak S. 2013. Agomelatine: an antidepressant with new potent hepatoprotective effects on paracetamol-induced liver damage in rats. Hum Exp Toxicol. 32:846–857.
  • Karcioglu SS, Palabiyik SS, Bayir Y, Karakus E, Mercantepe T, Halici Z, Albayrak A. 2015. The role of RAAS inhibition by Aliskiren on paracetamol-induced hepatotoxicity model in rats. J Cell Biochem. 117:638–646.
  • Kensler TW, Qian GS, Chen JG, Groopman JD. 2003. Translational strategies for cancer prevention in liver. Nat Rev Cancer. 3:321–329.
  • Kensler TW, Wakabayashi N, Biswal S. 2007. Cell survival responses to environmental stresses via the Keap1–Nrf2–ARE pathway. Annu Rev Pharmacol Toxicol. 47:89–116.
  • Kew MC. 2002. Epidemiology of hepatocellular carcinoma. Toxicology. 181–182:35–38.
  • Khan MA, Gupta A, Kumar S, Ahmad S, Sastry JLN. 2015. Hepatoprotective activity of a new polyherbal formulation against paracetamol and d-galactosamine induced hepatic toxicity. J Pharm Bioallied Sci. 7:246–249.
  • Khayyat A, Tobwala S, Hart M, Ercal N. 2016. N-acetylcysteine amide, a promising antidote for acetaminophen toxicity. Toxicol Lett. 241:133–142.
  • Kisaoglu A, Ozogul B, Turan MI, Yilmaz I, Demiryilmaz I, Atamanalp SS, Bakan E, Suleyman H. 2014. Damage induced by paracetamol compared with N-acetylcysteine. J Chin Med Assoc. 77:463–468.
  • Knight TR, Kurtz A, Bajt ML, Hinson JA, Jaeschke H. 2001. Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol Sci. 62:212–220.
  • Kobayashi M, Yamamoto M. 2005. Molecular mechanisms activating the Nrf2–Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal. 7:385–394.
  • Koen YM, Liu K, Shinogle H, Williams TD, Hanzlik RP. 2016. Comparative toxicity and metabolism of N-acyl homologues of acetaminophen and its isomer 3′-hydroxyacetanilide. Chem Res Toxicol. 29:1857–1864.
  • Konstandi M, Segos D, Galanopoulou P, Theocharis S, Zarros A, Lang MA, Marselos M, Liapi C. 2009. Effects of choline-deprivation on paracetamol- or phenobarbital-induced rat liver metabolic response. J Appl Toxicol. 29:101–109.
  • Koppen A, van Riel A, de Vries I, Meulenbelt J. 2014. Recommendations for the paracetamol treatment nomogram and side effects of N-acetylcysteine. Netherlands J Med. 72:251–257.
  • Kozer E, Evans S, Barr J, Greenberg R, Soriano I, Bulkowstein M, Petrov I, Chen-Levi Z, Barzilay B, Berkovitch M, et al. 2003. Glutathione, glutathione-dependent enzymes and antioxidant status in erythrocytes from children treated with high-dose paracetamol. Br J Clin Pharmacol. 55:234–240.
  • Kulo A, Peeters MY, Allegaert K, Smits A, de Hoon J, Verbesselt R, Lewi L, van de Velde M, Knibbe CAJ. 2013. Pharmacokinetics of paracetamol and its metabolites in women at delivery and post-partum. Br J Clin Pharmacol. 75:850–860.
  • Kumar G, Banu GS, Kannan V, Pandian MR. 2005. Antihepatotoxic effect of beta-carotene on paracetamol induced hepatic damage in rats. Indian J Exp Biol. 43:351–355.
  • Kumar RS, Asokkumar K, Murthy NV. 2011. Hepatoprotective effects and antioxidant role of Scutia myrtina on paracetamol induced hepatotoxicity in rats. J Complement Integr Med. 8:1–9.
  • Kurahashi T, Lee J, Nabeshima A, Homma T, Kang ES, Saito Y, Yamada S, Nakayama T, Yamada K-I, Miyata S, et al. 2016. Ascorbic acid prevents acetaminophen-induced hepatotoxicity in mice by ameliorating glutathione recovery and autophagy. Arch Biochem Biophys. 604:36–46.
  • Kuriakose GC, Kurup MG. 2010. Antioxidant and hepatoprotective activity of Aphanizomenon flos-aquae Linn against paracetamol intoxication in rats. Indian J Exp Biol. 48:1123–1130.
  • Kushwah DS, Salman MT, Singh P, Verma VK, Ahmad A. 2014. Protective effects of ethanolic extract of Nigella sativa seed in paracetamol induced acute hepatotoxicity in vivo. Pak J Biol Sci. 17:517–522.
  • Lahouel M, Boulkour S, Segueni N, Fillastre JP. 2004. The flavonoids effect against vinblastine, cyclophosphamide and paracetamol toxicity by inhibition of lipid-peroxidation and increasing liver glutathione concentration. Pathol Biol. 52:314–322.
  • Laukkanen MO, Leppanen P, Turunen P, Tuomisto T, Naarala J, Yla-Herttuala S. 2001. EC-SOD gene therapy reduces paracetamol-induced liver damage in mice. J Gene Med. 3:321–325.
  • Lee WM. 2008. Acetaminophen-related acute liver failure in the United States. Hepatol Res. 38:S3–S8.
  • Li W, Kong AN. 2009. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol Carcinogen. 48:91–104.
  • Li YJ, Shimizu T, Hirata Y, Inagaki H, Takizawa H, Azuma A, Kawada T, Sugawara I, Kudoh S, Sunazuka T, et al. 2013. EM, EM703 inhibit NF-kB activation induced by oxidative stress from diesel exhaust particle in human bronchial epithelial cells: importance in IL-8 transcription. Pulmon Pharmacol Ther. 26:318–324.
  • Lonare M, Kumar M, Raut S, More A, Doltade S, Badgujar P, Telang A. 2015. Evaluation of ameliorative effect of curcumin on imidacloprid-induced male reproductive toxicity in wistar rats. Environ Toxicol. 31:1250–1263.
  • Madi Almajwal A, Farouk Elsadek M. 2015. Lipid-lowering and hepatoprotective effects of Vitis vinifera dried seeds on paracetamol-induced hepatotoxicity in rats. Nutr Res Pract. 9:37–42.
  • Madkour FF, Abdel-Daim MM. 2013. Hepatoprotective and antioxidant activity of Dunaliella salina in paracetamol-induced acute toxicity in rats. Indian J Pharm Sci. 75:642–648.
  • Marotta F, Yadav H, Gumaste U, Helmy A, Jain S, Minelli E. 2009. Protective effect of a phytocompound on oxidative stress and DNA fragmentation against paracetamol-induced liver damage. Ann Hepatol. 8:50–56.
  • Mast C, Lyan B, Joly C, Centeno D, Giacomoni F, Martin J-F, Mosoni L, Dardevet D, Pujos-Guillot E, Papet I, et al. 2015. Assessment of protein modifications in liver of rats under chronic treatment with paracetamol (acetaminophen) using two complementary mass spectrometry-based metabolomic approaches. J Proteom. 120:194–203.
  • McGill MR, Lebofsky M, Norris H-RK, Slawson MH, Bajt ML, Xie Y, Williams CD, Wilkins DG, Rollins DE, Jaeschke H, 2013. Plasma and liver acetaminophen-protein adduct levels in mice after acetaminophen treatment: dose-response, mechanisms, and clinical implications. Toxicol Appl Pharmacol. 269:240–249.
  • McGill MR, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30:2174–2187.
  • McLoone P, Crombie IK. 1996. Hospitalisation for deliberate self-poisoning in Scotland from 1981 to 1993: trends in rates and types of drugs used. Br J Psychiatry. 169:81–85.
  • Miettinen TP, Bjorklund M. 2014. NQO2 is a reactive oxygen species generating off-target for acetaminophen. Mol Pharm. 11:4395–4404.
  • Miyakawa K, Albee R, Letzig LG, Lehner AF, Scott MA, Buchweitz JP, James LP, Ganey PE, Roth RA. 2015. A cytochrome P450-independent mechanism of acetaminophen-induced injury in cultured mouse hepatocytes. J Pharmacol Exp Ther. 354:230–237.
  • Mladenovic D, Radosavljević T, Ninković M, Vucević D, Jesić-Vukićević R, Todorović V. 2009. Liver antioxidant capacity in the early phase of acute paracetamol-induced liver injury in mice. Food Chem Toxicol. 47:866–870.
  • Mohamad NE, Yeap S, Lim K, Yusof H, Beh B, Tan S, Ho W, Sharifuddin S, Jamaluddin A, Long K, et al. 2015. Antioxidant effects of pineapple vinegar in reversing of paracetamol-induced liver damage in mice. Chin Med. 10:1–10.
  • Mohammed Abdalla H Jr, Soad Mohamed AG. 2010. In vivo hepato-protective properties of purslane extracts on paracetamol-induced liver damage. Malay J Nutr. 16:161–170.
  • Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. 2015. Overview review: comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain. 19:1213–1223.
  • Murray TV, Dong X, Sawyer GJ, Caldwell A, Halket J, Sherwood R, Quaglia A, Dew T, Anilkumar N, Burr S, et al. 2015. NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in mice. Free Radic Biol Med. 89:918–930.
  • Naggayi M, Mukiibi N, Iliya E. 2015. The protective effects of aqueous extract of Carica papaya seeds in paracetamol induced nephrotoxicity in male Wistar rats. Afr Health Sci. 15:598–605.
  • Nishikawa T, Araki E. 2007. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal. 9:343–353.
  • Nithianantham K, Shyamala M, Chen Y, Latha LY, Jothy SL, Sasidharan S. 2011. Hepatoprotective potential of Clitoria ternatea leaf extract against paracetamol induced damage in mice. Molecules (Basel, Switzerland). 16:10134–10145.
  • North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS, Tannenbaum SR, Zon LI, Goessling W. 2010. PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci USA. 107:17315–17320.
  • Nourjah P, Ahmad RS, Karwoski C, Willy M. 2006. Estimates of acetaminophen (paracetamol)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf. 15:398–405.
  • Nuttall SL, Khan JN, Thorpe GH, Langford N, Kendall MJ. 2003. The impact of therapeutic doses of paracetamol on serum total antioxidant capacity. J Clin Pharm Ther. 28:289–294.
  • O'Connell TM, Watkins PB. 2010. The application of metabonomics to predict drug-induced liver injury. Clin Pharmacol Ther. 88:394–399.
  • Okokon JE, Nwafor PA, Charles U, Dar A, Choudhary MI. 2013. Antioxidative burst and hepatoprotective effects of ethanol root extract of Hippocratea africana against paracetamol-induced liver injury. Pharm Biol. 51:872–880.
  • Oliver LH, Lewis SN. 2010. Acetaminophen. 7th ed. New York: McGraw-Hill; p. 1246–1252.
  • Oscier CD, Milner QJ. 2009. Peri-operative use of paracetamol. Anaesthesia. 64:65–72.
  • Ott P, Dalhoff K, Hansen PB, Loft S, Poulsen HE. 1990. Consumption, overdose and death from analgesics during a period of over-the-counter availability of paracetamol in Denmark. J Intern Med. 227:423–428.
  • Palabiyik SS, Karakus E, Akpinar E, Halici Z, Bayir Y, Yayla M, Kose D. 2016. The role of urotensin receptors in the paracetamol-induced hepatotoxicity model in mice: ameliorative potential of urotensin II antagonist. Basic Clin Pharmacol Toxicol. 118:150–159.
  • Pang C, Sheng YC, Jiang P, Wei H, Ji LL. 2015. Chlorogenic acid prevents acetaminophen-induced liver injury: the involvement of CYP450 metabolic enzymes and some antioxidant signals. J Zhejiang Univ Sci B. 16:602–610.
  • Parameswari SA, Chetty CM, Chandrasekhar KB. 2013. Hepatoprotective activity of Ficus religiosa leaves against isoniazid + rifampicin and paracetamol induced hepatotoxicity. Pharmacogn Res. 5:271–276.
  • Perez MJ, Gonzalez-Sanchez E, Gonzalez-Loyola A, Gonzalez-Buitrago JM, Marin JJG. 2011. Mitochondrial genome depletion dysregulates bile acid- and paracetamol-induced expression of the transporters Mdr1, Mrp1 and Mrp4 in liver cells. Br J Pharmacol. 162:1686–1699.
  • Pingili RB, Pawar AK, Challa SR. 2015. Systemic exposure of paracetamol (acetaminophen) was enhanced by quercetin and chrysin co-administration in Wistar rats and in vitro model: risk of liver toxicity. Drug Dev Ind Pharm. 41:1793–1800.
  • Placke ME, Wyand DS, Cohen SD. 1987. Extrahepatic lesions induced by acetaminophen in the mouse. Toxicol Pathol. 15:381–387.
  • Polat M, Cerrah S, Albayrak B, Ipek S, Arabul M, Aslan F, Yilmaz O. 2015. Assessing the effect of leptin on liver damage in case of hepatic injury associated with paracetamol poisoning. Gastroenterol Res Pract. 2015:357360–357368.
  • Prill S, Bavli D, Levy G, Ezra E, Schmälzlin E, Jaeger MS, Schwarz M, Duschl C, Cohen M, Nahmias Y, et al. 2016. Real-time monitoring of oxygen uptake in hepatic bioreactor shows CYP450-independent mitochondrial toxicity of acetaminophen and amiodarone. Arch Toxicol. 90:1181–1191.
  • Pu S, Ren L, Liu Q, Kuang J, Shen J, Cheng S, Zhang Y, Jiang W, Zhang Z, Jiang C, et al. 2016. Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity. Br J Pharmacol. 173:66–76.
  • Pujos-Guillot E, Pickering G, Lyan B, Ducheix G, Brandolini-Bunlon M, Glomot F, Dardevet D, Dubray C, Papet I. 2012. Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids. Age (Dordrecht, Netherlands). 34:181–193.
  • Radosavljevic T, Mladenovic D, Vucevic D, Vukicevic RJ. 2010. The role of oxidative/nitrosative stress in pathogenesis of paracetamol-induced toxic hepatitis. Med Pregled. 63:827–832.
  • Ramachandra Setty S, Quereshi AA, Viswanath Swamy AHM, Patil T, Prakash T, Prabhu K, Veeran Gouda A. 2007. Hepatoprotective activity of Calotropis procera flowers against paracetamol-induced hepatic injury in rats. Fitoterapia. 78:451–454.
  • Randle LE, Sathish JG, Kitteringham NR, Macdonald I, Williams DP, Park BK. 2008. alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice. Br J Pharmacol. 153:820–830.
  • Rasool MK, Sabina EP, Ramya SR. 2010. Hepatoprotective and antioxidant effects of gallic acid in paracetamol-induced liver damage in mice. J Pharm Pharmacol. 62:638–643.
  • Reen RK, Karan M, Singh K, Karan V, Johri RK, Singh J. 2001. Screening of various Swertia species extracts in primary monolayer cultures of rat hepatocytes against carbon tetrachloride- and paracetamol-induced toxicity. J Ethnopharmacol. 75:239–247.
  • Rice KM, Meduru S, Kakarla SK, Katta A, Mupparaju SP, Kidd B, Goebel LJ, Blough ER. 2012. Chronic paracetamol treatment influences indices of reactive oxygen species accumulation in the aging Fischer 344 X Brown Norway rat aorta. Ann Clin Lab Sci. 42:152–161.
  • Rocha JB, Gabriel D, Zeni G, Posser T, Siqueira L, Nogueira CW, Folmer V. 2005. Ebselen and diphenyl diselenide change biochemical hepatic responses to overdosage with paracetamol. Environ Toxicol Pharmacol. 19:255–261.
  • Roy P, Das S, Auddy RG, Saha A, Mukherjee A. 2013. Engineered andrographolide nanoparticles mitigate paracetamol hepatotoxicity in mice. Pharm Res. 30:1252–1262.
  • Sakran M, Selim Y, Zidan N. 2014. A new isoflavonoid from seeds of Lepidium sativum L. and its protective effect on hepatotoxicity induced by paracetamol in male rats. Molecules (Basel, Switzerland). 19:15440–15451.
  • Sasidharan S, Aravindran S, Latha LY, Vijenthi R, Saravanan D, Amutha S. 2010. In vitro antioxidant activity and hepatoprotective effects of Lentinula edodes against paracetamol-induced hepatotoxicity. Molecules (Basel, Switzerland). 15:4478–4489.
  • Sathya A, Siddhuraju P. 2013. Protective effect of bark and empty pod extracts from Acacia auriculiformis against paracetamol intoxicated liver injury and alloxan induced type II diabetes. Food Chem Toxicol. 56:162–170.
  • Schmidt LE, Dalhoff K. 2003. The impact of current tobacco use on the outcome of paracetamol poisoning. Aliment Pharmacol Ther. 18:979–985.
  • Senthilkumar R, Chandran R, Parimelazhagan T. 2014. Hepatoprotective effect of Rhodiola imbricata rhizome against paracetamol-induced liver toxicity in rats. Saudi J Biol Sci. 21:409–416.
  • Shaukat Z, Liu D, Hussain R, Khan M, Gregory SL. 2016. The role of JNK signalling in responses to oxidative DNA damage. Curr Drug Targets. 17:154–163.
  • Sheen CL, Dillon JF, Bateman DN, Simpson KJ, Macdonald TM. 2002. Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM. 95:609–619.
  • Shi J, Sun B, Shi W, Zuo H, Cui D, Ni L, Chen J. 2015. Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumour Biol. 36:655–662.
  • Simeonova R, Vitcheva V, Kondeva-Burdina M, Krasteva I, Manov V, Mitcheva M. 2013. Hepatoprotective and antioxidant effects of saponarin, isolated from Gypsophila trichotoma Wend. on paracetamol-induced liver damage in rats. Biomed Res Int. 757126:1–10.
  • Sindhu ER, Firdous AP, Preethi KC, Kuttan R. 2010. Carotenoid lutein protects rats from paracetamol-, carbon tetrachloride- and ethanol-induced hepatic damage. J Pharm Pharmacol. 62:1054–1060.
  • Singh S, Singh SK, Kumar M, Chandra K, Singh R. 2011. Ameliorative potential of quercetin against paracetamol-induced oxidative stress in mice blood. Toxicol Int. 18:140–145.
  • Sinthorn W, Chatuphonprasert W, Chulasiri M, Jarukamjorn K. 2016. Thai red rice extract provides liver protection in paracetamol-treated mice by restoring the glutathione system. Pharm Biol. 54:770–779.
  • Somanawat K, Thong-Ngam D, Klaikeaw N. 2013. Curcumin attenuated paracetamol overdose induced hepatitis. World J Gastroenterol. 19:1962–1967.
  • Swomley AM, Butterfield DA. 2015. Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics. Arch Toxicol. 89:1669–1680.
  • Trettin A, Böhmer A, Suchy M-T, Probst I, Staerk U, Stichtenoth DO, Frölich JC, Tsikas D. 2014. Effects of paracetamol on NOS, COX, and CYP activity and on oxidative stress in healthy male subjects, rat hepatocytes, and recombinant NOS. Oxid Med Cell Long. 2014:212576.
  • Vakiloddin S, Fuloria N, Fuloria S, Dhanaraj SA, Balaji K, Karupiah S. 2015. Evidences of hepatoprotective and antioxidant effect of Citrullus colocynthis fruits in paracetamol induced hepatotoxicity. Pak J Pharm Sci. 28:951–957.
  • Valvassori SS, Resende WR, Lopes-Borges J, Mariot E, Dal-Pont GC, Vitto MF, Luz G, de Souza CT, Quevedo J. 2015. Effects of mood stabilizers on oxidative stress-induced cell death signaling pathways in the brains of rats subjected to the ouabain-induced animal model of mania: mood stabilizers exert protective effects against ouabain-induced activation of the cell death pathway. J Psychiatr Res. 65:63–70.
  • Vliegenthart A, Kimmitt RA, Seymour JH, Homer NZ, Clarke JI, Eddleston M, Gray A, Wood DM, Dargan PI, Cooper JG, et al. 2017. Circulating acetaminophen metabolites are toxicokinetic biomarkers of acute liver injury. Clin Pharmacol Ther. 101:531–540.
  • Voloshchuk ON, Kopylchuk GP. 2016. Activity of liver mitochondrial NAD+-dependent dehydrogenases of the krebs cycle in rats with acetaminophen-induced hepatitis developed under conditions of alimentary protein deficiency. Biomed Khim. 62:169–172.
  • Wallace CI, Dargan PI, Jones AL. 2002. Paracetamol overdose: an evidence based flowchart to guide management. Emerg Med J. 19:202–205.
  • Wang X, Wu Q, Wan D, Liu Q, Chen D, Liu Z, Martínez-Larrañaga MR, Martínez MA, Anadón A, Yuan Z. 2016a. Fumonisins: oxidative stress-mediated toxicity and metabolism in vivo and in vitro. Arch Toxicol. 90:81–101.
  • Wang X, Martínez MA, Wu Q, Ares I, Martínez-Larrañaga MR, Anadón A, Yuan Z. 2016b. Fipronil insecticide toxicology: oxidative stress and metabolism. Crit Rev Toxicol. 46:876–899.
  • Wang X, Martínez M-A, Dai M, Chen D, Ares I, Romero A, Castellano V, Martínez M, Rodríguez JL, Martínez-Larrañaga M-R, et al. 2016c. Permethrin-induced oxidative stress and toxicity and metabolism. A review. Environ Res. 149:86–104.
  • Wang XW, Hussain SP, Huo T-I, Wu C-G, Forgues M, Hofseth LJ, Brechot C, Harris CC. 2002. Molecular pathogenesis of human hepatocellular carcinoma. Toxicology. 181–182:43–47.
  • Wang Y, Li D, Cheng N, Gao H, Xue X, Cao W, Sun L. 2015. Antioxidant and hepatoprotective activity of vitex honey against paracetamol induced liver damage in mice. Food Funct. 6:2339–2349.
  • Wang Y, Jiang Y, Fan X, Tan H, Zeng H, Wang Y, Chen P, Huang M, Bi H. 2015. Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol Lett. 236:82–89.
  • Weber D, Davies MJ, Grune T. 2015. Determination of protein carbonyls in plasma, cell extracts, tissue homogenates, isolated proteins: focus on sample preparation and derivatization conditions. Redox Biol. 5:367–380.
  • Weidinger A, Kozlov AV. 2015. Biological activities of reactive oxygen and nitrogen species: oxidative stress versus signal transduction. Biomolecules. 5:472–484.
  • Wendel A, Jaeschke H, Gloger M. 1982. Drug-induced lipid peroxidation in mice—II. Protection against paracetamol-induced liver necrosis by intravenous liposomally entrapped glutathione. Biochem Pharmacol. 31:3601–3605.
  • Whelton A, Hamilton CW. 1991. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 31:588–598.
  • Winker M, Faika D, Gulyas H, Otterpohl R. 2008. A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater. Sci Total Environ. 399:96–104.
  • Winnike JH, Li Z, Wright FA, Macdonald JM, O'Connell TM, Watkins PB. 2010. Use of pharmaco-metabonomics for early prediction of acetaminophen-induced hepatotoxicity in humans. Clin Pharmacol Ther. 88:45–51.
  • Xu JJ, Hendriks BS, Zhao J, de Graaf D. 2008. Multiple effects of acetaminophen and p38 inhibitors: towards pathway toxicology. FEBS Lett. 582:1276–1282.
  • Yabe Y, Kobayashi N, Nishihashi T, Takahashi R, Nishikawa M, Takakura Y, Hashida M. 2001. Prevention of neutrophil-mediated hepatic ischemia/reperfusion injury by superoxide dismutase and catalase derivatives. J Pharmacol Exp Ther. 298:894e9.
  • Yang H, Jiang T, Li P, Mao Q. 2015. The protection of glycyrrhetinic acid (GA) towards acetaminophen (APAP)-induced toxicity partially through fatty acids metabolic pathway. Afr Health Sci. 15:1023–1027.
  • Yang HY, Lee TH. 2015. Antioxidant enzymes as redox-based biomarkers: a brief review. BMB Rep. 48:200–208.
  • Yang X, Zhan Y, Sun Q, Xu X, Kong Y, Zhang J. 2017. Adenosine 5′-monophosphate blocks acetaminophen toxicity by increasing ubiquitination-mediated ASK1 degradation. Oncotarget. 8:6273–6282.
  • Yao H-T, Yang Y-C, Chang C-H, Yang H-T, Yin M-C. 2015. Protective effects of (–)-epigallocatechin-3-gallate against acetaminophen-induced liver injury in rats. Biomedicine. 5:16–21.
  • Yayla M, Halici Z, Unal B, Bayir Y, Akpinar E, Gocer F. 2014. Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats. Eur J Pharmacol. 726:87–95.
  • Yoon E, Babar A, Choudhary M, Kutner M, Pyrsopoulos N. 2016. Acetaminophen-induced hepatotoxicity: a comprehensive update. J Clin Transl Hepatol. 4:131–142.
  • Yousef MI, Omar SA, El-Guendi MI, Abdelmegid LA. 2010. Potential protective effects of quercetin and curcumin on paracetamol-induced histological changes, oxidative stress, impaired liver and kidney functions and haematotoxicity in rat. Food Chem Toxicol. 48:3246–3261.
  • Yu H, Barrass N, Gales S, Lenz E, Parry T, Powell H, Thurman D, Hutchison M, Wilson ID, Bi L, et al. 2015. Metabolism by conjugation appears to confer resistance to paracetamol (acetaminophen) hepatotoxicity in the cynomolgus monkey. Xenobiotica; Fate Foreign Comp Biol Syst. 45:270–277.
  • Yu J, Jiang Y-S, Jiang Y, Peng Y-F, Sun Z, Dai X-N, Cao Q-T, Sun Y-M, Han J-C, Gao Y-J, et al. 2014. Targeted metabolomic study indicating glycyrrhizin’s protection against acetaminophen-induced liver damage through reversing fatty acid metabolism. Phytother Res. 28:933–936.
  • Zamora R, Vodovotz Y, Billiar TR. 2000. Inducible nitric oxide synthase and inflammatory diseases. Mol Med (Cambridge, MA). 6:347–373.
  • Zhou F, Sun W, Zhao M. 2015b. Controlled formation of emulsion gels stabilized by salted myofibrillar protein under malondialdehyde (MDA)-induced oxidative stress. J Agric Food Chem. 63:3766–3777.
  • Zhou X, Cheung CM, Yang JM, Or PM, Lee WY, Yeung JH. 2015a. Danshen (Salvia miltiorrhiza) water extract inhibits paracetamol-induced toxicity in primary rat hepatocytes via reducing CYP2E1 activity and oxidative stress. J Pharm Pharmacol. 67:980–989.
  • Zubairi MB, Ahmed JH, Al-Haroon SS. 2014. Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits. Indian J Pharmacol. 46:644–648.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.